C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2004
11/30/2004	US6824774 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/30/2004	US6824773 TWEAK receptor
11/30/2004	CA2267072C Reconstituted human anti-hm1.24 antibody
11/30/2004	CA2238439C Method for preparation of type ii collagen
11/30/2004	CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/25/2004	WO2004101824A1 Method of detecting chronic obstructive pulmonary disease
11/25/2004	WO2004101805A1 Method for recombinant production of mammalian proteins and proteins obtainable by such method
11/25/2004	WO2004101768A2 Recombinant comamonas testosreroni 5-mgam-4d amids and carboxylic acid production
11/25/2004	WO2004101740A2 Clotting factor-fc chimeric proteins to treat hemophilia
11/25/2004	WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004	WO2004101737A2 A novel adjuvant capable of specifically activating the adaptive immune response
11/25/2004	WO2004101619A1 Rational design and synthesis of functional glycopeptide
11/25/2004	WO2004101601A1 Protein refolding apparatus and method of using the same
11/25/2004	WO2004101598A2 Insertion of furin protease cleavage sites in membrane proteins and uses thereof
11/25/2004	WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004	WO2004064724A3 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
11/25/2004	WO2004063346A3 Lysozyme transgenic ungulates
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004	US20040236077 Capable of specifically reacting with the N-terminal region of a partial peptide in a polypeptide with a specific amino acid sequence, used for diagnosis of pregnancy
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235716 Novel cyclosporins
11/25/2004	US20040235173 Production of host cells containing multiple integrating vectors by serial transduction
11/25/2004	US20040235140 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235112 Enzymatic polypeptide for use in detection of modulators for prevention a nd treatment of inflammatory, cell proliferative and autoimmune diseases; enzyme inhibitors
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235090 Fermenting somatotropin from transgenic escherichia and using dipeptidyl aminopeptidase to modify terminal; bioreactors and heterologous gene expression
11/25/2004	US20040235089 denaturing genetically engineered growth hormones, interferons, interleukins, immunogens or lymphokines obtained from host cells, using solutions of mercapto-organic solvents and urea, then renaturing using buffers, buffer to obtain protein in it's bioactive form
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235058 ULBP antibodies
11/25/2004	US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004	US20040235029 In vitro translation system
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234979 Differentiall-expressed and up-regulated polynucleotides and polypeptides in breast cancer
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234535 novel live vaccines for control of F. columnare in channel catfish comprising one or more rifampicin resistant mutants of F. columnare, created by multiple passaging of the native isolate on increasing concentrations of rifampicin
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234521 Antigen detection segments; crosslinking receptors
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	CA2525899A1 Ovr110 antibody compositions and methods of use
11/25/2004	CA2525870A1 Liver x receptor .alpha. splicing mutant protein, gene thereof and use thereof
11/25/2004	CA2520604A1 Insertion of furin protease cleavage sites in membrane proteins and uses thereof
11/24/2004	EP1479776A1 Cell extract for cell-free protein synthesis and process for producing the same
11/24/2004	EP1479771A2 Method to screen phage display libraries with different ligands
11/24/2004	EP1479770A1 Surface expression libraries of randomized peptides
11/24/2004	EP1479697A1 Tick chitinase
11/24/2004	EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004	EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478769A2 Phytases, nucleic acids encoding them and methods for making and using them
11/24/2004	EP1478764A2 Humanized collagen antibodies and related methods
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478753A1 Genetic sequences having methyltransferase activity and uses therefor
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478740A2 Heteromultimeric tnf ligand family members
11/24/2004	EP1478738A1 Anti-ccr5 antibody
11/24/2004	EP1478736A2 High-level production of amyloid-beta peptides from imr-32 cells
11/24/2004	EP1478733A2 Cold shock inducible expression and production of heterologous polypeptides
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1430082A4 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
11/24/2004	EP1390503A4 Novel nucleic acid molecules
11/24/2004	EP1381625B1 Mutants of green fluorescent protein
11/24/2004	EP1303539B1 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
11/24/2004	EP1233984B1 PROCESS FOR PRODUCING WASP POISON ALLERGENS WITH REDUCED IgE-REACTIVITY
11/24/2004	EP1024830B1 Antigen vectors in the form of multilamellar vesicles
11/24/2004	EP0826064B1 Low oxygen affinity mutant hemoglobin
11/24/2004	EP0656012B1 T cell epitopes of ryegrass pollen allergen
11/24/2004	EP0551438B1 Surface expression libraries of randomized peptides
11/24/2004	CN1549861A Method for secretory production of glycoprotein having human-type sugar chain using plant cell
11/24/2004	CN1549857A Testicular carnitine transporter and its gene
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549825A Purification process
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004	CN1549823A Production of high molecular mass lectins
11/24/2004	CN1549821A A system for antibody expression and assembly
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
11/24/2004	CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/24/2004	CN1548540A Polypeptide enzyme surface exhibiting technology and C-end polypeptide enzyme surface exhibition of cholesteryl ester transfer protein
11/24/2004	CN1548526A High-yield engineering bacterium of nicomycin x component and its application
11/24/2004	CN1548459A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
11/24/2004	CN1548458A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
11/24/2004	CN1177050C Coding polynucleotide of human protein with function of suppressing cancer cell growth
11/24/2004	CN1177049C Coding polynucleotide of human protein with function of suppressing cancer cell growth

1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 1125